U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07411261) titled 'PremaBiom: Metatranscriptomics of the Respiratory Microbiome to Predict the Occurrence of Bronchopulmonary Dysplasia in Preterm Infants' on Feb. 04.
Brief Summary: The goal of this clinical trial is to understand the impact of respiratory microbiome maturation in respiratory health of preterm infants under 32 gestational weeks. The main questions it aims to answer are:
* What is the role of microbiome maturation in respiratory health (development of bronchopulmonary dysplasia, childhood asthma and viral respiratory infections) of preterm infants ?
* Which environmental or health factors are involved in the maturation of the respir...